) and/or depression ) and agreed pharmacists can have positive interventions in these situations ; depression: median 6 IR [5] [6] [7] 
Introduction
With one in ten Americans now taking an antidepressant medication, there is greater need for pharmacist's interventions. 1 MTM is defined as a distinct service or group of services that optimize therapeutic outcomes for individual patients [that] are independent of, but can occur in conjunction with, the provision of drug product. 2 Currently, pharmacists provide MTM in a variety of settings such as physician offices and community pharmacies. These sessions can be both comprehensive as well as focused on a specific An anonymous, self-administered, electronic survey containing 60 questions was distributed to all 350 licensed pharmacists in a supermarket pharmacy chain who received basic MTM training. To distribute the survey, each pharmacist received an email containing the link to the survey using the Qualtrics system. Respondents were asked to complete the survey within two weeks of the survey announcement. A reminder email containing the survey link was distributed three times -at one week before the survey closed, at one day before close, and one to extend the deadline for 3 days (over a weekend) to increase the survey response rate. As the purpose of the survey was to assess existing willingness and barriers to providing pain and depression MTM services, a control group was not selected, and no additional intervention took place.
Survey respondents were asked to rate each statement using a Likert-type scale, where strongly disagree was assigned a value of one, moderately disagree a value of two, slightly disagree a value of three, neither disagree or agree a value of four, slightly agree a value of five, moderately agree a value of six, and strongly agree a value of seven ( Pharmacists strongly agreed they would benefit from additional training regarding pain (median 7 IR [6] [7] ) and depression (median 7 IR [6] [7] ) management MTM. In regards to additional training, respondents were given a list of the following items and asked to rank the forms of additional training based on what they most prefer: Continuing Education (CE), Review Article, Live Presentation, Web Presentation, and Kroger Television (KTV, an internal television network used for training and associate communications). Continuing Education (CE) was ranked as most preferred form of additional training followed by live presentation, web presentation, review article, and KTV. When asked to rank the given disease states in order of their comfort level, pharmacists felt most comfortable with hypertension (37.6% of respondents ranking as most preferred) followed by diabetes, dyslipidemia, pain, and depression.
Additionally, statistically significant differences were observed when respondents with a BSPharm degree were compared to those with a PharmD degree. Compared to pharmacists with a BSPharm degree, pharmacists with a PharmD degree responded more positively to several statements ( Table 2) . Discussion
In 2009, a similar study was performed assessing pharmacists' perceptions regarding implementation of medication therapy management reported that pharmacists had a desire for additional disease state training. 5 Many pharmacists within this supermarket pharmacy chain receive diabetes-specific coaching and training, which may be one reason for the level of comfort with diabetes-related issues. Interestingly, pharmacists did not report feeling strongly confident and/or adequately trained to provide MTM for pain management or depression, but did report feeling strongly confident and/or adequately trained to provide MTM for diabetes. Current literature indicates there is a link between diabetes and depression, thus impacting a diabetic's quality of life. 6 It may be important to identify these areas of weakness and continue to build upon them to strengthen the application of the MTM encounter. Also, the accessibility of community pharmacists puts them in a prime position for these types of interventions as most pharmacists are available after hours and on weekends.
Several differences were found between those pharmacists with a BSPharm degree compared to those with a PharmD degree. Interestingly pharmacists with a PharmD degree agreed more strongly with statements related to knowledge with patient assessment tools and adequate training to provide MTM for diabetes. Knowledge of differences in pharmacists based on their training may help employers and leaders to understand what additional training may be helpful to different populations of pharmacists.
Some pharmacists seemed concerned that the dispensing volume may impact the ability to offer MTM. Busier stores (those filling an average of >1500 per week) answered similarly to slower stores (those filling an average of <1500 per week). Although pharmacies with different dispensing volumes may have different challenges when incorporating MTM into the practice workflow, it does not appear that dispensing volume may be a major determinant as to the feasibility of incorporation of MTM.
The strengths of this survey are that the survey participants are involved with MTM at their current practice site, 83% of pharmacists in this supermarket pharmacy chain have conducted at least one MTM encounter in the past year. A potential limitation of this study is that only pharmacists in a certain area were included and this supermarket pharmacy chain may have more emphasis on MTM than other pharmacies. Pharmacists in other regions may have different experience or opinions towards pain and mental health MTM, and may have different scopes of practices based on state law that may be more or less supportive of MTM and direct patient care. The response rate of 53% is also a limitation of this study as it could be higher, but was still thought to provide useful information for follow-up and planning. Also, despite efforts to communicate that answers were confidential, some pharmacists may have felt concern about possible repercussions of their responses, and may not have answered truthfully. A limitation regarding the survey design was that when asked about average number of MTM sessions the pharmacists completed per period, those who completed zero MTM were lumped in the same category as those who completed 1-5 MTM sessions. However, MTM is an expectation of all pharmacists in this corporate division and during the last calendar year, approximately 300 pharmacists participated in MTM. Thus, the authors felt it was reasonable to have a category devoted to minimal MTM experience.
As more and more pharmacies are looking to incorporate both general and targeted MTM into their workflow, it can be important for those in leadership to understand the major barriers (i.e., workflow and education), and may find it interesting to specifically note that pharmacists showed slight agreement with the statement that job satisfaction may improve if they conducted more MTM sessions. Along those same lines, those in leadership may find it valuable to know that on average, pharmacists moderately agreed that they would benefit from additional training regarding pain and depression management MTM, and that CE was the preferred route. This may empower pharmacist to reach out to their colleagues to develop strategies for reviewing disease states where pharmacists feel less comfortable.
Conclusion
Pharmacists are interested in and believe patients would benefit from MTM specifically for pain management and depression. Barriers to MTM focused on pain and depression were pharmacist training and work flow issues with the MTM process. There are opportunities to overcome these barriers with continuing education and live presentations, and incorporating technicians into the work flow as technicians can play a key role in the MTM process. Further research on how best to prepare pharmacists for a wide variety of direct patient care opportunities should be conducted. 
